For the clinically diagnosed HCC, the sensitivity and specificity are only 41–65% and 80–90% for AFP7, 56–77% and 82–87% for DCP8, and 28–56% and 92–97% for AFP-L39, respectively. The gene discussed is AFP; the disease is hepatocellular carcinoma.